Metropolis Healthcare Q4 Revenue Grows 23% on B2B, Wellness

Metropolis Healthcare's Q4FY26 revenue grew 23% YoY, driven by strong B2B (30% growth) and B2C (19% growth) channels.
Recent acquisitions (Core Diagnostics, DAPIC, etc.) are integrated, with Core Diagnostics showing margin improvement in Q4.
Organic growth (excluding acquisitions) was 14.5% with EBITDA margin expansion due to operating leverage.